Study comparing dual combination of product (budesonide and formoterol) given via two different inhalers. To see which one results in the best effect on breathing.

Trial Identifier: D5980C00023
Sponsor: AstraZeneca
NCTID:: NCT04078126
Start Date: September 2019
Primary Completion Date: December 2020
Study Completion Date: December 2020
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
German Translation

Trial Locations

Country Location
Germany Frankfurt/Main, Germany, 60389
Germany Gauting, Germany, 82131
Germany Hannover, Germany, D-30173
Germany Landsberg, Germany, 86899